A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder

This study has been completed.

Sponsor:

Information provided by:

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

ClinicalTrials.gov Identifier:

NCT00326300

First received: May 12, 2006

Last updated: May 20, 2011

Last verified: April 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	August 2007
Estimated Primary Completion Date:	No date given

No publications provided by McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Adler LA, Orman C, Starr HL, Silber S, Palumbo J, Cooper K, Berwaerts J, Harrison DD. Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study. J Clin Psychopharmacol. 2011 Feb;31(1):108-14.

To Top